iKang Launches Zhihui Kang Cloud IaaS Open Platform to Accelerate Digital and Intelligent Transformation in the Health Screening Industry

On December 6, the 2024 Ikang Smart Health Cloud Conference was held in Beijing. At the event, Ikang Group announced the establishment of the Ikang Smart Health Cloud IaaS Open Platform (IaaS: Innovation/Infrastructure as a Service). Leveraging its two major systems, iKangCloud+ and iKangOS+, Ikang will open up its artificial intelligence, genetic testing, specialized testing, health examination, queue management, reporting, data platform, and health management systems to third-party health examination centers and medical institutions, thereby building an open ecosystem.

The 2024 Ikang Zhihui Kangyun Conference was broadcast live in its entirety by CCTV Finance’s “Finance V Moment,” with Chen Weihong, a host from China Media Group, specially invited to preside over the event. Professor Wang Zhanshan, Standing Committee Member and Secretary-General of the Health Management Branch of the Chinese Medical Association, Secretary-General of the National Project Management Committee for Innovative Integration Pilot Projects on Major Chronic Disease Prevention and Control, and Secretary-General of the Working Committee for Pilot Projects on High-Quality Workplace Health Management, delivered an opening address. Keynote presentations were delivered by: Professor Feng Jianfeng, Dean and Distinguished Professor of the Institute of Science and Technology for Brain-inspired Intelligence and School of Data Science at Fudan University, as well as Professor in the Department of Computer Science at the University of Warwick, UK; Professor Bi Hongsheng, Chairman of the Ophthalmology Professional Committee of the China Association of Integrative Medicine, Deputy Head of the National Technical Guidance Group for Blindness Prevention under the National Health Commission, Vice President of the Ophthalmologist Branch of the Chinese Medical Doctor Association, Dean of the Affiliated Eye Hospital and School of Ophthalmology and Optometry of Shandong University of Traditional Chinese Medicine, and Dean of the Shandong Provincial Institute of Ophthalmic Prevention and Treatment; Professor Zhang Kai, Deputy Director of the Department of Cancer Prevention at the National Cancer Center/Cancer Hospital of the Chinese Academy of Medical Sciences; and Dr. Liu Xingyu, Co-founder and General Manager of Beijing Changmugu Medical Technology Co., Ltd. Zhang Ligang, Founder, Chairman, and CEO of Ikang Group, launched the Ikang Zhihui Kangyun IaaS Open Platform. The conference was jointly attended by Zhu Yeqing, Co-founder, Chairman, and CEO of New Horizon Health; Lei Li, Chief Operating Officer of Genetron Health; Jin Weirong, Chairman of Shanghai South Gene Technology Co., Ltd.; Zhang Dalei, Founder and Chairman of Airdoc; Qiao Xin, Co-founder, Chairman, and CEO of Deepwise Healthcare, and Vice Chairman of the China Association of Medical Equipment; Guo Na, Co-founder and General Manager of Huiyi Huiying; Fan Jianbing, Founder and CEO of Burning Rock Biotech; Xiong Lei, Founder and Chairman of 3D Medicines; Meng Qingbin, Chairman of Union Rock; Zhao Junlin, Co-founder and CTO of E-Titan Health; Sun Nengbiao, Marketing Director of Ameson Technology; as well as Gao Jianxiong, Vice President of Ikang Group’s Digital Innovation Center, and Luo Yuan, Vice President of Technology at Ikang Group, who joined hands to chart a blueprint for health.

At the event, Ikang officially launched the IaaS 2024 Alliance Program and held an intent-signing ceremony with its first batch of IaaS 2024 partners.

IaaS 2024 Alliance Program Launch Ceremony

In the new digital era of the Internet of Everything, with the rapid development of cutting-edge technologies such as artificial intelligence, cloud computing, and big data, the health management industry is undergoing a continuous and profound transformation. Against this backdrop, how to collaborate in building a new industrial ecosystem has become a core issue for the future.

Wang Zhanshan, Standing Committee Member and Secretary-General of the Health Management Branch of the Chinese Medical Association; Secretary-General of the Project Management Committee for the National Pilot Program on Innovative Integration in the Prevention and Control of Major Chronic Diseases; and Secretary-General of the Steering Committee for the Pilot Program on High-Quality Workplace Health Management, stated in his address: “The ‘Zhihui Kangyun Open Platform,’ jointly launched by Ikang and other partners, is a groundbreaking milestone. It will enable more small- and medium-sized health examination centers to benefit from shared resources—including advanced testing technologies, intelligent service systems, and professional training—thereby reducing costs, enhancing efficiency, and achieving greater results with less effort. Furthermore, by actively implementing an innovative model that shifts focus from health examinations to comprehensive health management, and by operationalizing the overarching goal of transitioning from a treatment-centered approach to a health-centered one, this initiative plays a positive role in promoting and guiding the future development of health management. These encouraging actions demonstrate a proactive assumption of social responsibility and contribute to advancing the Healthy China initiative.”

Standing Committee Member and Secretary-General, Health Management Branch of the Chinese Medical Association

Secretary-General, Project Management Committee for the National Pilot Program on Innovative Integration in the Prevention and Control of Major Chronic Diseases

Wang Zhanshan, Secretary-General of the Working Committee for the Pilot Program on High-Quality Workplace Health Management

As artificial intelligence (AI) becomes deeply integrated with the healthcare sector, it has emerged as a critical lever for addressing the current scarcity of high-quality medical resources. Jianfeng Feng, Dean and Distinguished Professor at the Institute of Science and Technology for Brain-inspired Intelligence and the School of Data Science at Fudan University, as well as Professor in the Department of Computer Science at the University of Warwick, UK, pointed out: “Brain health has become a global focal point. Early identification and precise diagnosis are key to the prevention and treatment of brain disorders. AI empowerment will make the diagnosis and treatment of brain diseases more traceable and evidence-based, heralding new hope for the future. Furthermore, the widespread application of AI holds significant importance for promoting equitable access to high-quality medical resources, enhancing the accuracy of disease diagnoses, and improving the efficiency of health management.”

Dean and Distinguished Professor, Institute of Science and Technology for Brain-inspired Intelligence and School of Data Science, Fudan University

Professor Jianfeng Feng, Department of Computer Science, University of Warwick, UK

How Can Artificial Intelligence Promote the High-Quality Development of Eye Health Medical Service Systems? Professor Bi Hongsheng, Chairman of the Ophthalmology Professional Committee of the China Association of Integrative Medicine, Deputy Leader of the National Technical Guidance Group for Blindness Prevention under the National Health Commission, and Vice President of the Ophthalmologist Branch of the Chinese Medical Doctor Association; as well as Dean of the Affiliated Eye Hospital and School of Ophthalmology and Optometry of Shandong University of Traditional Chinese Medicine, and Director of the Shandong Provincial Institute of Ophthalmic Disease Prevention and Control, shared insights on the application of AI in myopia prevention and control among children and adolescents, as well as in fundus disease screening: “AI can effectively improve diagnostic accuracy. For instance, in the three stages of myopia management—screening, prevention, and treatment—a data-driven ‘three-tier early warning’ system with self-learning capabilities can predict whether students will develop pseudo-myopia or true myopia within six months to a year. This includes predictions of the prevalence rates of true myopia, pseudo-myopia, and pre-clinical myopia, with an accuracy exceeding 90%, laying a solid foundation for early prevention and control. Regarding early screening and diagnosis of blinding eye diseases in China, studies have shown that AI algorithm models achieve an accuracy of 95.3%–99.9% in distinguishing ten types of fundus diseases. Their diagnostic capability is comparable to that of senior fundus specialists, while reducing screening time by approximately 75%. Artificial intelligence helps address the shortage of ophthalmic medical resources, making standardized and convenient fundus screening possible.”

Professor Bi Hongsheng, Chairman of the Ophthalmology Committee of the China Association of Integrative Medicine; Deputy Head of the National Technical Guidance Group for Blindness Prevention under the National Health Commission; Vice President of the Ophthalmologist Branch of the Chinese Medical Doctor Association; Dean of the Affiliated Eye Hospital and the School of Ophthalmology and Optometry, Shandong University of Traditional Chinese Medicine; and Director of the Shandong Provincial Institute of Ophthalmic Prevention and Treatment.

Amid the trend of population aging, China’s cancer burden continues to intensify. Zhang Kai, Deputy Director of the Department of Cancer Prevention at the National Cancer Center/Cancer Hospital of the Chinese Academy of Medical Sciences, stated, “Early screening, early diagnosis, and early treatment are effective approaches to alleviating the cancer burden. These measures not only provide patients with a chance of cure but also significantly reduce the financial burden on families. With the increasing adoption of more precise non-invasive initial cancer screening methods, including liquid biopsy, a greater number of high-risk individuals are participating in early screening programs, thereby improving screening efficacy and accelerating the rapid development of early detection initiatives.”

National Cancer Center

Zhang Kai, Deputy Director of the Department of Cancer Prevention, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences

Furthermore, bone health issues have become a widespread health challenge affecting the Chinese population. Addressing orthopedics as one of the blind spots in routine health screenings, Ikang incorporated AI-based lower limb joint health assessments into its health checkup packages for the first time in 2023. Dr. Liu Xingyu, Co-founder and General Manager of Beijing Changmugu Medical Technology Co., Ltd., shared insights on how artificial intelligence empowers orthopedics: “AI can deeply learn from the clinical expertise of top-tier physicians, enabling precise screening and intelligent assessment of osteoarthritis. Changmugu and Ikang have jointly built an integrated platform covering prevention, screening, diagnosis, treatment, and rehabilitation, thereby achieving high-quality, full-cycle management of bone health.”

Beijing Changmugu Medical Technology Co., Ltd.

Dr. Liu Xingyu, Co-founder and General Manager

At the event, Zhang Ligang, Founder, Chairman, and CEO of Ikang Group, made a major announcement of the IaaS 2024 Plan and unveiled the establishment of the Ikang Open Ecosystem Platform. He stated, “The wave of medical AI and digitalization is unstoppable. For the health checkup industry to achieve sustainable development, it must embrace innovative technologies such as artificial intelligence, genetic testing, and medical big data. As a pioneer in preventive medicine, Ikang is committed to enabling more industry peers to share smart healthcare solutions and co-build a new industrial ecosystem through the Ikang Zhihui Kangyun IaaS Open Platform, benefiting customers and collaborating with partners in the health checkup and health management sectors.”

Zhang Ligang, Founder, Chairman and CEO of Ikang Group

Ikang, which has possessed a strong Internet DNA since its inception, has been advancing over the past two decades with the mission of “driving the transformation of health and medical service models through innovative technology.” As early as 2017, Ikang, standing from the user’s perspective, launched its “managed” physical examination service through a strategic upgrade, truly elevating physical examinations into comprehensive health management services.

In 2018, to build a “bridge” between prevention and clinical care and address issues such as diagnostic gaps in routine health examinations for certain major diseases, iKang fully launched the iKang AI+ Initiative. Over the past six years, it has successively introduced more than 10 artificial intelligence products covering specialized screenings for the fundus, breast, heart, cerebrovascular system, teeth, and bones, establishing an initially scaled “iKang AI Matrix.” The company has provided AI-driven and genetic testing services to tens of millions of individuals.

Zhang Ligang, Founder, Chairman and CEO of Ikang Group

In 2021, Ikang completed the deployment of its medical cloud, establishing the first cloud platform in China’s health examination industry to serve tens of millions of users. To date, it has aggregated approximately 70 million sets of big data from health examinations. “Prior to 2021, Ikang’s 154 health examination, dental, and medical centers across 59 cities nationwide conducted image interpretation independently. After migrating to the cloud, these operations have been consolidated into 16 centralized image interpretation centers, covering 173 health examination, dental, and medical centers in 57 cities across China as of now. Currently, data from every X-ray, CT scan, MRI, and electrocardiogram (ECG) performed at Ikang is transmitted to the cloud in real time. AI software deployed on the cloud performs initial screening and classification of this information. This not only enables real-time access to examination results and enhances diagnostic accuracy through AI-assisted image interpretation, but also facilitates intelligent prediction of health risks, allowing physicians to make targeted assessments of pathological changes based on these data and annotations. Through the Ikang Zhihuikang Cloud IaaS Open Platform, these capabilities are shared with third-party health examination centers and healthcare institutions,” introduced Zhang Ligang.

Leveraging medical AI and digitalization to provide more comprehensive health protection for customers has become a core competency of Ikang’s development. To maximize the accessibility of healthcare, and building on its years of forward-looking layout and practical experience in AI-empowered health management, Ikang has chosen to launch the Ikang Zhihui Kangyun IaaS Open Platform on its 20th anniversary. This initiative aims to popularize high-quality, AI-enhanced medical resources for a broader population by fostering a new ecosystem within the physical examination industry.

Ikang Zhihui Kangyun IaaS Open Platform

The iKang Zhihui Kangyun IaaS Open Platform comprises two major systems: the Intelligent Medical Product Open Platform (iKangCloud+) and the Commercial Operating System Open Platform (iKangOS+). Specifically, iKangCloud+ will provide third-party health examination centers and medical institutions with Ikang’s introduced products in artificial intelligence, genetic testing, proteomics, and innovative diagnostics. Meanwhile, iKangOS+ will empower third-party health examination centers and medical institutions by fully opening up its health examination system, patient guidance system, Laboratory Information System (LIS), Picture Archiving and Communication System (PACS), data analytics, reporting system, and health management system.

Ikang’s first AI health assistant, ikkie, will also be launched on the Ikang Zhihui Kangyun IaaS Open Platform. Gao Jianxiong, Vice President of Ikang Group’s Digital Innovation Center, demonstrated ikkie’s applications across the entire health examination scenario. Powered by technologies such as Retrieval-Augmented Generation (RAG), its services cover all stages—pre-examination, during examination, and post-examination—providing customers with a new experience that is real-time, intelligent, precise, and interconnected. Over the past year, ikkie has served more than 570,000 customers, with over 1.9 million queries answered.

Gao Jianxiong, Vice President of the Digital Innovation Center at Ikang Group

Leveraging Ikang’s robust and stable technical infrastructure, the Ikang Zhihui Kangyun IaaS Open Platform exhibits five key characteristics encapsulated by the acronym “S-H-A-R-E”: Secure, High-Performance, Accessible, Real-time, and Extensive.

To strictly safeguard the commercial interests of third-party physical examination centers and medical institutions, as well as customers’ personal privacy, Luo Yuan, Vice President of Technology at Ikang Group, stated: “Data on the Ikang Zhihui Kangyun IaaS Open Platform is completely isolated from Ikang’s internal system data. There is no need to upload customers’ sensitive identity information. Key data is stored with encryption, data transmission employs Chinese national cryptographic algorithms, imaging data is physically deleted, and enterprise data is logically isolated.”

Luo Yuan, Vice President of Technology at Ikang Group

As another key segment of the conference, Ikang Health Technology Inc., together with partners including New Horizon Health, Genetron Health, Southern Gene, Airdoc, Deepwise Medical, Huiyi Huiying, Basecare Medical, Changmugu Medical, 3D Medicines, Union Rock, Yitikang, and Ameson, jointly launched the IaaS 2024 Alliance Initiative to collaboratively promote the robust development of the health management industry. Subsequently, the signing ceremony for the first batch of partner intentions for the Ikang Zhihui Kangyun IaaS Open Platform was successfully held, with Ikang completing agreements with dozens of third-party health examination centers and medical institutions.

IaaS 2024 Alliance Program Launch Ceremony

Ikang Zhihui Kangyun IaaS Open Platform integrates all health checkup scenarios, forming a comprehensive, implementable, replicable, and scalable standardized health management solution designed to equip partner checkup centers and medical institutions with an “intelligent brain.” On one hand, it helps partner checkup centers and medical institutions expand in-depth testing, enhance medical quality, improve customer experience, facilitate client acquisition, and further strengthen competitiveness. On the other hand, it assists them in reducing fixed asset investments, alleviating shortages of high-quality medical resources, offering more value-added services, increasing revenue and profitability, thereby improving operational efficiency.

Adhering to the principle of “healthcare for the public benefit,” the Ikang Zhihui Kangyun IaaS Open Platform has achieved the integration and interoperability of innovative technological resources, making high-quality health checkups and health management services more accessible to the general population. Meanwhile, it builds a “digital bridge” to facilitate the decentralization of AI-enhanced premium medical resources, breaking down barriers of time, space, and institutions, so that residents in grassroots and remote areas can enjoy convenient, efficient, precise, and comprehensive health management services right at their doorstep.

Furthermore, by transitioning from standalone product and technical services to an integrated platform matrix, and through the joint development of a unified smart healthcare cloud, the Ikang Zhihui Kang Cloud IaaS Open Platform is committed to driving transformation in the health examination industry model, facilitating the upgrade and restructuring of the industrial ecosystem, and building an industrial ecosystem based on co-creation, sharing, and mutual benefit.

With many companions on the journey, we can go far. Looking to the future, Ikang will continue to leverage its leading technological, service, and innovation capabilities to build a robust, real-world industrial ecosystem. Guided by the principles of “openness, innovation, collaboration, integration, and sharing,” Ikang is committed to empowering peers in health check-ups and health management with their digital and intelligent transformation, jointly contributing to strengthening the health foundation for public well-being.

Scan the QR code

Apply for a Trial of IaaS Platform Products